Graft Polymer PLC - London-based company focused on the development and production of polymer modification, biological supplements, and nano-drug delivery systems - Says completion and commissioning.
Graft Polymer Plc (LON:GPL – Get Rating) insider Alex Brooks bought 56,399 shares of the business’s stock in a transaction that occurred on Monday, May 15th. The shares were bought at an average price of GBX 5 ($0.06) per share, with a total value of £2,819.95 ($3,532.44). Graft Polymer Price Performance Shares of Graft Polymer […]
Graft Polymer (UK) PLC said it is targeting "several key initiatives" to increase product and sales growth this year after a busy and productive 12 months.
Barclays Tops FTSE 100 After Corporate, Investment Banking-Driven 1Q Beat 0949 GMT - Barclays sits at the top of London's blue chip index after the British bank posted first-quarter results ahead of expectations, driven by a beat in its fixed incom. | 07:07am